Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.

Prior to a chimpanzee adenovirus-based (ChAd63) malarial vaccine trial, sera were collected to assess ChAd63-specific neutralizing antibody titers in Banfora (Burkina Faso). The low neutralizing antibody titers reported in both adults and children (median titers, 139.1 and 35.0, respectively) are en...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Nébié, I, Edwards, N, Tiono, AB, Ewer, K, Sanou, G, Soulama, I, Sanon, S, Diarra, A, Yaro, J, Kangoye, D, Imoukhuede, E, Hill, A, Sirima, S
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: 2014